Extracellular glutamate accumulation following cerebral ischemia leads to overactivation of glutamate receptors, thereby resulting in intracellular Ca2+ overload and excitotoxic neuronal injury. Multiple attempts have been made to counteract such effects by reducing glutamate receptor function, but none have been successful. In this minireview, we present the available evidence regarding the role of all types of ionotropic and metabotropic glutamate receptors in cerebral ischemia and propose phased treatment strategies based on glutamate receptors in both the acute and post-acute phases of cerebral ischemia, which may help realize the clinical application of glutamate receptor antagonists
AbstractIn this study, we investigated whether the increase of inhibitory γ-amino butyric acid (GABA...
Neural cell death plays a crucial role in the pathogenesis of various ischaemic disorders of the cen...
Objective: Blood/brain-glutamate grabbing is an emerging concept in the treatment of acute ischemic ...
An accumulation of experimental data suggests that N-methyl-D-aspartate (NMDA) receptor antagonists ...
Excitotoxicity is the principle mechanism of acute injury during stroke. It is defined as the unregu...
Although experimental studies have widely shown that the pharmacological blockade of ionotropic glut...
Glutamate is a fundamental excitatory neurotransmitter in the mammalian central nervous system (CNS)...
The N-methyl-D-aspartate (NMDA) type of glutamate receptor is a calcium-permeable ion channel with i...
Abstract We have recently shown that pharmacological blockade of mGlu2 metabotropic glutamate recept...
Stroke is one of the leading causes of death and disability in the world, of which ischemia accounts...
Stroke is the second highest reason of death in the world and the leading cause of disability. The i...
Introduction: This review of literature is to demonstrate a role of group III metabotropic glutamate...
Ischemic brain damage is largely due to excitotoxicity mediated by glutamate receptors, notably the ...
The destructive mechanisms associated with stroke are initiated by activation of glutamate receptors...
We examined the influence of type 4 metabotropic glutamate (mGlu4) receptors on ischemic brain damag...
AbstractIn this study, we investigated whether the increase of inhibitory γ-amino butyric acid (GABA...
Neural cell death plays a crucial role in the pathogenesis of various ischaemic disorders of the cen...
Objective: Blood/brain-glutamate grabbing is an emerging concept in the treatment of acute ischemic ...
An accumulation of experimental data suggests that N-methyl-D-aspartate (NMDA) receptor antagonists ...
Excitotoxicity is the principle mechanism of acute injury during stroke. It is defined as the unregu...
Although experimental studies have widely shown that the pharmacological blockade of ionotropic glut...
Glutamate is a fundamental excitatory neurotransmitter in the mammalian central nervous system (CNS)...
The N-methyl-D-aspartate (NMDA) type of glutamate receptor is a calcium-permeable ion channel with i...
Abstract We have recently shown that pharmacological blockade of mGlu2 metabotropic glutamate recept...
Stroke is one of the leading causes of death and disability in the world, of which ischemia accounts...
Stroke is the second highest reason of death in the world and the leading cause of disability. The i...
Introduction: This review of literature is to demonstrate a role of group III metabotropic glutamate...
Ischemic brain damage is largely due to excitotoxicity mediated by glutamate receptors, notably the ...
The destructive mechanisms associated with stroke are initiated by activation of glutamate receptors...
We examined the influence of type 4 metabotropic glutamate (mGlu4) receptors on ischemic brain damag...
AbstractIn this study, we investigated whether the increase of inhibitory γ-amino butyric acid (GABA...
Neural cell death plays a crucial role in the pathogenesis of various ischaemic disorders of the cen...
Objective: Blood/brain-glutamate grabbing is an emerging concept in the treatment of acute ischemic ...